Contraception for women: An evidence based overview

BMJ (Online)

Volumn 339, Issue 7720, 2009, Pages 563-568

  Amy, Jean Jacques ^a,c   Tripathi, Vrijesh ^b  

^a European Journal of Contraception and Reproductive Health Care   (Belgium)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^c NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CYCLOSPORIN; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; DESOGESTREL; DROSPIRENONE; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GESTODENE; GRISEOFULVIN; LAMOTRIGINE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MODAFINIL; NEVIRAPINE; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENYTOIN; POTASSIUM SPARING DIURETIC AGENT; PRIMIDONE; RIFAMPICIN; RITONAVIR; SPERMICIDAL AGENT; TOPIRAMATE; TRANEXAMIC ACID; UNINDEXED DRUG;

ACNE; AMENORRHEA; AWARENESS; BARRIER CONTRACEPTION; BLEEDING; BONE DENSITY; CLINICAL TRIAL; CONDOM; CONTRACEPTION; COUNSELING; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RELEASE; DRUG SAFETY; DRUG WITHDRAWAL; DYSMENORRHEA; ECTOPIC PREGNANCY; EMERGENCY CONTRACEPTION; ENDOMETRIUM CANCER; EVIDENCE BASED PRACTICE; FAMILY PLANNING; FEMALE; FERTILITY; HEALTH PROMOTION; HORMONAL CONTRACEPTION; HUMAN; INJECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTATIONAL AMENORRHEA; LOW DRUG DOSE; LUNG EMBOLISM; MASTALGIA; MENOPAUSAL SYNDROME; MENORRHAGIA; MENSTRUAL CYCLE; META ANALYSIS; METRORRHAGIA; MOOD CHANGE; OBSERVATIONAL STUDY; OVARY CANCER; OVARY CYST; OVULATION; PATIENT COMPLIANCE; PATIENT SATISFACTION; PELVIC INFLAMMATORY DISEASE; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SIDE EFFECT; SPOTTING; SYSTEMATIC REVIEW; TABLET FORMULATION; TREATMENT INDICATION; UTERINE TUBE OCCLUSION; VAGINAL INJURY; VENOUS THROMBOEMBOLISM; WORLD HEALTH ORGANIZATION;

CONTRACEPTION; CONTRACEPTION, BARRIER; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; COUNSELING; DRUG INTERACTIONS; FEMALE; HUMANS; INTRAUTERINE DEVICES; PROGESTINS;

EID: 69949106368     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2895     Document Type: Review

References (28)

1. Singh S, Darroch JE, Vlassoff M, Nadeau J. Adding it up: the benefits of investing in sexual and reproductive health care. New York: Alan Guttmacher Institute, 2003. www.guttmacher.org/pubs/addingitup.pdf.
2. United Nations Department of Economics and Social Affairs Population Division. World contraceptive use. 2007. ww.un.org/esa/population/publications/ contraceptive2007/contraceptive-2007-table.pdf.
3. Lopez LM, Steiner M, Grimes DA, Schulz KF. Strategies for communication effectiveness. Cochrane Database Syst Rev 2008;(4):CD006964.
4. WHO. Selected practice recommendations for contraceptive use: 2008 update. 2008. www.who.int/reproductive-health/publications/spr/spr-2008-update. pdf (click on "Family planning" first.
5. WHO. Medical eligibility criteria for contraceptive use. 3rd ed. 2004. www.who.int/reproductivehealth/publications/family-planning/9789290215080/en/ index.html.
6. Lopez LM, Newmann SJ, Grimes DA, Nanda K, Schulz KF. Immediate start of hormonal contraceptives for contraception. Cochrane Database Syst Rev 2008;(2):CD006260. (Pubitemid 351807330)
7. Lopez LM, Grimes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 2008;(1):CD003552.
8. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Stewart F, Nelson A, Cates W, Guest F, et al, eds. Contraceptive technology. 18th ed. New York: Ardent Media, 2004:355-363
9. El-Ibiary SY, Cocohoba JM. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. Eur J Contracept Reprod Health Care 2008;13:123-132
10. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet 2008;371:303-314
11. Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998;179:577-582
12. Martinez F, Avecilla A. Combined hormonal contraception and venous thromboembolism. Eur J Contracept Reprod Health Care 2007;12:97-106. (Pubitemid 46897780)
13. Wu O, Robertson L, Langhorne P, Twaddle S, Lowe GD, Clarke P, et al. Oral contraceptives, hormonal replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thromb Haemost 2005;94:17-25. (Pubitemid 40974700)
14. Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 2007;109:339-346 (Pubitemid 46197426)
15. Grimes DA, Lopez LM, Manion C, Schulz KF. Cochrane systematic reviews of IUD trials: lessons learned. Contraception 2007;75(suppl):S55-9. (Pubitemid 46783810)
16. Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002;57:120-128 (Pubitemid 34132150)
17. Varma R, Sinha D, Gupta JK. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) - a systematic enquiry and overview. Eur J Obstet Gynecol Reprod Biol 2006;125:9-28. (Pubitemid 43303727)
18. Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev 2006;(3):CD006034. (Pubitemid 46841270)
19. Hubacher D, Lara-Ricalde R, Taylor DJ, Guerra-Infante F, Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001;345:561-567 (Pubitemid 32772097)
20. Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies. Contraception 1995;52:23-34.
21. Grimes DA, Gallo MF, Halpern V, Nanda K, Schulz KF, Lopez LM. Fertility awareness-based methods for contraception. Cochrane Database Syst Rev 2007;(3):CD004860.
22. Van der Wijden C, Kleinen J. Lactational amenorrhea for family planning. Cochrane Database Syst Rev 2003;(4):CD001329.
23. Cheng L, Gülmezoglu AM, van Oel CJ, Piaggio G, Ezcurra E, van Look PF. Interventions for emergency contraception. Cochrane Database Syst Rev 2007;(4):CD001324.
24. Task Force on Postovulatory Methods of Fertility Regulation. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Lancet 1999;353:697-702.
25. Von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:1803-1810 (Pubitemid 35449417)
26. Polis CB, Schaffer K, Blanchard K, Glasier A, Harper C, Grimes DA. Advance provision of emergency contraception for pregnancy prevention. Cochrane Database Syst Rev 2007;(2):CD005497. (Pubitemid 351805701)
27. Raymond EG, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol 2007;109:181-188 (Pubitemid 46035523)
28. Hillis SD, Marchbanks PA, Ratliff Tylor L, Peterson HB. Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol 1999;93:889-895